Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
6.38 %
$ 36 M
Market Cap
-2.59
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
44.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
RenovoRx, Inc.
RNXT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart RNXT
EBIT FORECAST
EBIT Forecast Chart RNXT
NET INCOME FORECAST
Net Income Chart RNXT